Zinkal Padalia

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

CRISPR Therapeutics (Switzerland)(Current)

Zinkal Padalia is an author at CRISPR Therapeutics (Switzerland) specializing in t cell biology, life sciences, and chimeric antigen receptor t-cell therapy.

Publications per year

2018–2023

Publications

Preclinical Development of CTX120, an Allogeneic CAR-T Cell Targeting Bcma

Henia Dar, Daniel B. Henderson, Zinkal Padalia et al. · Blood · 2018 · 23 citations

Life Sciences, Immunology, Oncology +14

Abstract ND02: CTX112 and CTX131: Next-generation CRISPR/Cas9-engineered allogeneic (allo) CAR T cells incorporating novel edits that increase potency and efficacy in the treatment of lymphoid and solid tumors

Jonathan Terrett, Demetrios Kalaitzidis, Mary‐Lee Dequéant et al. · Cancer Research · 2023 · 17 citations

Life Sciences, Immunology, Oncology +17

1–2 of 2